1. Home
  2. MPLT vs BHRB Comparison

MPLT vs BHRB Comparison

Compare MPLT & BHRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MapLight Therapeutics Inc.

MPLT

MapLight Therapeutics Inc.

HOLD

Current Price

$0.00

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Logo Burke & Herbert Financial Services Corp.

BHRB

Burke & Herbert Financial Services Corp.

HOLD

Current Price

$69.34

Market Cap

1.4B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
MPLT
BHRB
Founded
2018
1852
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.4B
IPO Year
2025
2023

Fundamental Metrics

Financial Performance
Metric
MPLT
BHRB
Price
N/A
$69.34
Analyst Decision
Buy
Analyst Count
5
Target Price
N/A
$71.80
AVG Volume (30 Days)
N/A
80.5K
Earning Date
09-24-2026
04-23-2026
Dividend Yield
N/A
3.46%
EPS Growth
N/A
173.76
EPS
N/A
2.16
Revenue
N/A
N/A
Revenue This Year
N/A
$36.62
Revenue Next Year
N/A
$10.06
P/E Ratio
N/A
$31.87
Revenue Growth
N/A
N/A
52 Week Low
N/A
$57.42
52 Week High
N/A
$75.09

Technical Indicators

Market Signals
Indicator
MPLT
BHRB
Relative Strength Index (RSI) 31.34 36.11
Support Level $10.67 $68.38
Resistance Level $20.20 $70.71
Average True Range (ATR) 0.79 1.28
MACD 0.08 -0.26
Stochastic Oscillator 16.14 10.15

Price Performance

Historical Comparison
MPLT
BHRB

About MPLT MapLight Therapeutics Inc.

MapLight Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing treatments for central nervous system disorders. Its discovery platform identifies neural circuits causally linked to disease and targets them for therapeutic modulation, aiming to improve efficacy, safety, tolerability, and ease of use. The company was founded by leaders in psychiatry and neuroscience research to address the lack of circuit-specific pharmacotherapies. Its product candidate, ML-007C-MA, is a fixed-dose combination of an M1/M4 muscarinic agonist and a peripherally acting anticholinergic, being developed for schizophrenia and Alzheimer's disease psychosis, designed to activate central receptors while mitigating peripheral side effects.

About BHRB Burke & Herbert Financial Services Corp.

Burke & Herbert Financial Services Corp is the bank holding company. Through its subsidiary, it predominantly serves small to medium-sized businesses, their owners and employees, professional corporations, non-profits, and individuals with various banking products and financial services. Some of its products and service offerings include checking, savings, and money market accounts, certificates of deposit, treasury and cash management services, commercial and industrial loans, commercial real estate loans, residential mortgage, acquisition, construction, and development loans, online banking, mobile banking, and wealth and trust services. The company operates in a single segment, namely Community Banking.

Share on Social Networks: